Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
US9790204B2 · kind B2 · utility
2Cited by
2References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2015 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Aug 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.